echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Boan Biological publishes the research results of the new crown neutralizing antibody in a sub-issue of the journal Nature

    Boan Biological publishes the research results of the new crown neutralizing antibody in a sub-issue of the journal Nature

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com




    • The FALA mutation introduced into LY-CovMab eliminates the binding to Fc receptor or complement receptor to avoid the ADE effect (antibody-dependent enhancement) that is often accompanied by antiviral antibodies;
    • LY-CovMab shows a long half-life, and the terminal elimination half-life in mice and rhesus monkeys is 9.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.